Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data BreachAccesswire • 05/16/24
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMeAccesswire • 05/14/24
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsGlobeNewsWire • 05/14/24
Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseBusiness Wire • 04/30/24
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 04/24/24
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024GlobeNewsWire • 04/05/24
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?The Motley Fool • 03/24/24
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6GlobeNewsWire • 03/20/24
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years AgoGlobeNewsWire • 03/19/24
Fed-up 23andMe users lash out at the company, accusing it of scamming them into auto-renewalBusiness Insider • 03/13/24